Probiotics may alleviate symptoms of hay fever, which may be related to bacteria in our gut and nose.

Published Date: 26 Apr 2023

The dreaded hay fever signs, including itchy eyes, sneezing, and a stuffy nose, have arrived for many people with the arrival of spring. Up to 42% of people experience hay fever, making it a widespread condition. Immune system overreaction is the cause of it.

Read Full News

Latest News

Adding Radiotherapy to NAC Shows No Survival Benefit in PDAC

For patients with resectable pancreatic cancer, adding radiotherapy to neoadjuvant chemotherapy may improve pathological response, but that doesn’t translate into better outcomes.

Real-World Data Favor Upadacitinib in Bio-Exposed UC

A Portuguese real-world study finds that upadacitinib outperforms tofacitinib and ustekinumab — top-tier options after UC treatment failure — with higher remission rates at 16 and 52 weeks.

FDA Okays RAS Inhibitor Daraxonrasib for Pancreatic Cancer

Daraxonrasib is being hailed as a potential game changer for metastatic pancreatic cancer, roughly doubling survival vs chemotherapy in previously treated patients.

FDA Approves Zanidatamab Regimen for HER2-Positive GEA

Zanidatamab with tislelizumab and chemotherapy leads to overall survival of 26.4 months.

Fibermaxxing? Your Microbes (and Your Health) Say Thanks.

Scientists are making progress understanding how a fiber-rich diet can help with chronic disease.

How Strong Is Antioxidants’ Link to Cervical Cancer Risk?

While the rationale behind a beneficial effect of antioxidants on risk has merit, the study’s limitations prevent actionable conclusions.

Todays Updates

Faster 1-Hour MI Rule-Out Is Safe

The 1-hour troponin pathway was safely implemented in a real-world study but did not impact workflow in busy emergency departments.

Edoxaban Falls Short After Intracranial Hemorrhage in AF

Edoxaban reduced ischemic stroke after intracranial hemorrhage in patients with AF, but excess hemorrhagic stroke and major bleeding offset the benefit.

Drug Benefit Seen in Nonobstructive HCM

A multicenter phase 3 trial has associated a cardiac myosin inhibitor with meaningful clinical benefit in nonobstructive HCM, for which there has been no effective therapies.

Tailored Approach Shortens Endocarditis Therapy

Tailored antibiotic therapy for infective endocarditis was associated with a significant reduction in treatment duration, according to an open-label multicenter trial.

Todays Updates

Faster 1-Hour MI Rule-Out Is Safe

The 1-hour troponin pathway was safely implemented in a real-world study but did not impact workflow in busy emergency departments.

Edoxaban Falls Short After Intracranial Hemorrhage in AF

Edoxaban reduced ischemic stroke after intracranial hemorrhage in patients with AF, but excess hemorrhagic stroke and major bleeding offset the benefit.

Drug Benefit Seen in Nonobstructive HCM

A multicenter phase 3 trial has associated a cardiac myosin inhibitor with meaningful clinical benefit in nonobstructive HCM, for which there has been no effective therapies.

Tailored Approach Shortens Endocarditis Therapy

Tailored antibiotic therapy for infective endocarditis was associated with a significant reduction in treatment duration, according to an open-label multicenter trial.

Latest News

For patients with resectable pancreatic cancer, adding radiotherapy to neoadjuvant chemotherapy may improve pathological response, but that doesn’t translate into better outcomes.

A Portuguese real-world study finds that upadacitinib outperforms tofacitinib and ustekinumab — top-tier options after UC treatment failure — with higher remission rates at 16 and 52 weeks.

Daraxonrasib is being hailed as a potential game changer for metastatic pancreatic cancer, roughly doubling survival vs chemotherapy in previously treated patients.

Zanidatamab with tislelizumab and chemotherapy leads to overall survival of 26.4 months.

Scientists are making progress understanding how a fiber-rich diet can help with chronic disease.

While the rationale behind a beneficial effect of antioxidants on risk has merit, the study’s limitations prevent actionable conclusions.

News All Time

Iceberg Blamed in Diarrhea Outbreak; Masking Urged in Cities; DEA's Ketamine Probes

Health news and commentary gathered by MedPage Today staff

What's the Best Way to Test for Cyclospora Infection?

Microscopy and DNA tests are both viable, but sensitivity, cost, and availability vary

930 Dead in Outbreak; FDA Backtracks on Iceberg Lettuce; Chronic Cough Drug Fizzles

Health news and commentary gathered by MedPage Today staff

Novel Drug Shows Promise in Crohn's, Ulcerative Colitis

Duvakitug may be suitable for patients previously treated with advanced therapy

Singing for Chronic Belching; Excess Cancers in Crohn's; Dual Agonist for Liver Fat

News and commentary from the world of gastroenterology and hepatology

Lettuce Supplier Still the Focus in Cyclospora Outbreak, Despite Faulty Test Result

FDA says its investigation and outbreak data continue to point to Taylor Farms' iceberg lettuce

Inside the Intestinal Crypt: Untold Stories of Cyclospora

There's still much to learn about the parasite's past, present, and future

FDA Approves New Blood Test for Colon Cancer Screening

SimpleScreen CRC is indicated for adults 45 and up at average risk

Cyclospora Boosts Fears That Deadlier Foodborne Outbreaks Are Ahead

Food safety leaders across the U.S. are raising alarms over federal cuts

Intensified Pre-Op Chemoradiotherapy Fails in Locally Advanced Rectal Cancer

DFS at 3 years nearly identical with the addition of irinotecan, but with more toxicity

Diabetes and Pancreas Cancer; Crohn's Tied to Joint Infections; Hypnotherapy for IBS

News and commentary from the world of gastroenterology and hepatology

Michigan Reports First Two U.S. Deaths Related to Diarrhea-Causing Parasite

The CDC says cyclosporiasis is rarely deadly

FIT-Based Screening Linked to Drop in Colorectal Cancer Mortality

Inflection point occurred around 2012, 3 years after screening program was implemented

Study Examines Link Between IBD and Psychiatric Disorders

Does psychiatric morbidity precede IBD onset or arise after diagnosis?

Pancreatic Cancer Vaccine Shows Interception Promise in High-Risk Patients

Durable immune response seen in patients with cancer precursor lesions

Best Gastro Hospitals; GI Bleeding in Jehovah's Witnesses; Steroids for DILI

News and commentary from the world of gastroenterology and hepatology

Recommended News For You

Research indicates that extended PSMA therapy is safe and effective for patients with prostate cancer.

ACS Guidelines Expand Lung Cancer Screening Eligibility -- Is That a Good Thing?

Global inequalities found in cancer research funding

EU Adds CAR-T Warning; New Blincyto Indication; Good News in Pancreatic Cancer

What Could This Exploratory 5-Year Survival Data in Adjuvant NSCLC Treatment Mean?

Can the way we talk about cancer change how we interact with the disease?

Early Identification of Ovarian Cancer; Allergy Medicine for NSCLC? Unfavorable Development for Anti-TIGIT Medication?

Recommended Articles For You

Targeting Cancer Stem Cells in Solid Tumors: Mechanisms, Clinical Implications, and Therapeutic Advances 

Tumor-Specific Fluorescent Peptide Navigation in Surgical Oncology 

Understanding the Causes and Symptoms of Cavernous Sinus Thrombosis  

Iron Deficiency Anemia: Challenges in Diagnosis and Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The Early Progression of Prostate Cancer Is Not Stopped by Metformin.

2.

Bladder cancer link to explosive ordnance exposure among Army veteran bomb disposal officers

3.

In Biochemically Recurrent Nonmetastatic Prostate Cancer, Apalutamide Presents Its Argument.

4.

A study on lung cancer provides additional proof of the value of screening.

5.

What does it mean for Biden's prostate cancer to be 'aggressive'? A urologic surgeon explains

1.

Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked

2.

Emicizumab in Infants with Severe Hemophilia A: HAVEN 7 Phase 3b Trial Insights

3.

The Latest Research on Basal Cell Carcinoma: New Developments in Diagnosis and Cure 

4.

Understanding Dasatinib: A Promising Drug for Cancer Treatment 

5.

Guideline Evolution in Benign Hematologic Conditions

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II

2.

Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC

3.

Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC

4.

Efficient Management of First line ALK-rearranged NSCLC - Part III

5.

Efficient Management of First line ALK-rearranged NSCLC - Part VI

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot